RaymondCWadlowMD

PubMed

• The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
  George Zogopoulos, Ido Haimi, Shenin A Sanoba, Jessica N Everett, Yifan Wang, Bryson W Katona, James J Farrell, Aaron J Grossberg, Salvatore Paiella, Kelsey A Klute, Y...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 1
• Quantitative proteomic analysis of HER2 protein expression in PDAC tumors.
  Jamie Randall, Allison L Hunt, Aratara Nutcharoen, Laura Johnston, Safae Chouraichi, Hongkun Wang, Arthur Winer, Justin Davis, Brian Corgiat, Nicholas W Bateman, Emanu...> ;Clinical Proteomics. 2024 Mar 20
• Concurrent BRAFV600E and BRCA Mutations in MSS Metastatic Colorectal Cancer: Prevalence and Case Series of mCRC patients with prolonged OS.
  Timothy Lewis Cannon, Jamie N Randall BA, Ethan S Sokol, Sonja M Alexander, Raymond C Wadlow, Arthur A Winer, Daniel M Barnett, Danny L Rayes BS, Halla S Nimeiri, Kimb...> ;Cancer Treatment and Research Communications. 2022 Jan 1
• 18 citations
  A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma
  Marc T. Roth, Dana Backlund Cardin, Erkut Borazanci, Margaux Steinbach, Vincent J. Picozzi, Alexander Rosemury, Raymond C. Wadlow, Jordan Berlin> ;The Oncologist. 2020 Oct 1
• 12 citations
  A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
  Lipika Goyal, Surendra Pal Chaudhary, Eunice L. Kwak, Thomas A. Abrams, Amanda Carpenter, Brian M. Wolpin, Raymond C. Wadlow, Jill N. Allen, Rebecca S. Heist, Nadine J...> ;Investigational New Drugs. 2020 Jan 2
• 40 citations
  PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in ope...
  Daniel P. Petrylak, Nicholas J. Vogelzang, Kamal Chatta, Mark D. Fleming, David Smith, Leonard Joseph Appleman, Arif Hussain, Manuel Modiano, Parminder Singh, Scott T....> ;The Prostate. 2020 Jan 1
• 8 citations
  Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
  Andrea J. Bullock, Keith Stuart, Susanna Jacobus, Thomas A. Abrams, Raymond C. Wadlow, Michael Goldstein, Rebecca A. Miksad> ;Journal of Gastrointestinal Oncology. 2017 Jul 26
• 2 citations
  Molecular Testing to Optimize and Personalize Decision Making in the Management of Colorectal Cancer
  Marwan Al-Hajeili, Anthony F. Shields, Jimmy J. Hwang, Raymond C Wadlow, John L. Marshall> ;Oncology. 2017 Apr 15
• 35 citations
  A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma.
  Lipika Goyal, Raymond C. Wadlow, Lawrence S. Blaszkowsky, Brian M. Wolpin, Thomas A. Abrams, Nadine Jackson McCleary, Susan Sheehan, Eamala Sundaram, Michael D. Karol,...> ;Investigational New Drugs. 2015 Feb 1
• 76 citations
  A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreat...
  Theodore S. Hong, David P. Ryan, Darrell R. Borger, Lawrence S. Blaszkowsky, Beow Y. Yeap, Marek Ancukiewicz, Vikram Deshpande, Shweta Shinagare, Jennifer Y. Wo, Yves ...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Jul 15
• 60 citations
  Mutational analysis and clinical correlation of metastatic colorectal cancer.
  Andrea L. Russo, Darrell R. Borger, Jackie Szymonifka, David P. Ryan, Jennifer Y. Wo, Lawrence S. Blaszkowsky, Eunice L. Kwak, Jill N. Allen, Raymond C. Wadlow, Andrew...> ;Cancer. 2014 May 15
• 61 citations
  A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
  Jennifer A. Chan, Lawrence S. Blaszkowsky, Keith Stuart, Andrew X. Zhu, Jill N. Allen, Raymond C. Wadlow, David P. Ryan, Jeffrey A. Meyerhardt, Marielle Gonzalez, Eile...> ;Cancer. 2013 Sep 1
• 21 citations
  Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
  Nils D. Arvold, Christopher G. Willett, Carlos Fernandez-del Castillo, David P. Ryan, Cristina R. Ferrone, Jeffrey W. Clark, Lawrence S. Blaszkowsky, Vikram Deshpande,...> ;International Journal of Radiation Oncology, Biology, Physics. 2012 Jul 1
• 55 citations
  Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.
  Nils D. Arvold, David P. Ryan, Andrzej Niemierko, Lawrence S. Blaszkowsky, Eunice L. Kwak, Jennifer Y. Wo, Jill N. Allen, Jeffrey W. Clark, Raymond C. Wadlow, Andrew X...> ;Cancer. 2012 Jun 15
• Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab.
  Wadlow, R. C., Hezel, A. F., Abrams, T. A., Blaszkowsky, L. S., Fuchs, C. S., Kulke, M. H., Kwak, E. L., Meyerhardt, J. A., Ryan, D. P., Szymonifka, J., Wolpin, B. M.,...> ;Oncologist. 2012 Jun 06
• Immediate versus delayed adjuvant chemoradiation for resected pancreatic cancer: An analysis of local control and survival.
  Childs SK, Mamon HJ, Wo JY, Blaszkowsky LS, Fernandez-Del Castillo C, Swanson R, Wolpin BM, Kwak EL, Allen JN, Zhu AX, Clark JW, Wadlow RC, Ryan DP, Hong TS> ;J. Clin. Oncol.. 2012-02-01
• 63 citations
  Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab
  Raymond C. Wadlow, Aram F. Hezel, Thomas A. Abrams, Lawrence S. Blaszkowsky, Charles S. Fuchs, Matthew H. Kulke, Eunice L. Kwak, Jeffrey A. Meyerhardt, David P. Ryan, ...> ;The Oncologist. 2012 Jan 1
• Mutational analysis and clinical correlation of 185 consecutive metastatic colorectal patients: Similarities and differences between colon and rectal patients.
  Russo AL, Borger DR, Ryan DP, Fan KC, Lopez H, Scialabba V, Blaszkowsky LS, Kwak EL, Clark JW, Allen JN, Wadlow RC, Zhu AX, Wang R, Dias-Santagata D, Hong TS, Iafrate AJ> ;J. Clin. Oncol.. 2011-05-20
• Gastric adenocarcinoma treated with radiation with or without epirubicin-based chemotherapy: Evaluation of radiation-induced liver disease.
  Schoenfeld JD, Mamon HJ, Blaszkowsky LS, Enzinger PC, Wo JY, Allen JN, Wadlow RC, Ryan DP, Hong TS> ;J. Clin. Oncol.. 2011-02-01
• 22 citations
  The role of targeted agents in preoperative chemoradiation for rectal cancer
  Raymond C. Wadlow, David P. Ryan> ;Cancer. 2010 Aug 1
• 2223 citations
  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
  David A. Barbie, Pablo Tamayo, Jesse S. Boehm, So Young Kim, Susan Moody, Ian F. Dunn, Anna C. Schinzel, Peter Sandy, Etienne Meylan, Claudia Scholl, Stefan Fröhling, ...> ;Nature. 2009 Nov 5
• 20 citations
  Systems-Level Modeling of Cancer-Fibroblast Interaction
  Raymond C. Wadlow, Ben S. Wittner, S. Aidan Finley, Henry Bergquist, Rabi Upadhyay, Stephen P. Finn, Massimo Loda, Umar Mahmood, Sridhar Ramaswamy> ;Plos One. 2009 Sep 3
• 422 citations
  Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.
  Claudia Scholl, Stefan Fröhling, Ian F. Dunn, Anna C. Schinzel, David A. Barbie, So Young Kim, Serena J. Silver, Pablo Tamayo, Raymond C. Wadlow, Sridhar Ramaswamy, Ko...> ;Cell. 2009 May 29
• 33 citations
  DNA microarrays in clinical cancer research.
  Raymond C. Wadlow, Sridhar Ramaswamy> ;Current Molecular Medicine. 2005 Jan 31
• 17 citations
  Umbilical cord blood transplantation: where do we stand?
  Raymond C Wadlow, David L. Porter> ;Biology of Blood and Marrow Transplantation. 2002 Dec 1
• Join now to see all